Differentiated thyroid carcinoma
-
Part 2 book "Thyroid diseases - Pathogenesis, diagnosis and treatment" includes content: Classification and etiopathogenesis of hypothyroidism, congenital hypothyroidism, central hypothyroidism, diagnosis and treatment of hypothyroidism, treatment of graves’ disease, pathogenesis of thyroid carcinoma, differentiated thyroid carcinoma of follicular origin,... and other contents.
334p dianmotminh03 17-06-2024 1 0 Download
-
To compare the clinicopathological features between children (≤ 18 years) and adults with differentiated thyroid carcinoma (DTC). Subject and method: A descriptive study on 50 children and 158 adults with DTC at the 108 Military Central Hospital from January 2015 to March 2022.
7p vilarry 12-03-2024 3 2 Download
-
Papillary thyroid carcinoma accounts for the most common type of thyroid cancer of well-differentiated type. Papillary thyroid carcinoma is featured by biologically low-grade and less aggressive tumors with a survival rate of 10 years in most of the diagnosed cases.
8p vitiki 30-01-2024 6 2 Download
-
Primary thyroid lymphoma (PTL) and papillary thyroid carcinoma (PTC) are both thyroid malignancies, but their therapeutic methods and prognosis are different. This study aims to explore their sonographic and computed tomography(CT)features, and to improve the early diagnosis rate.
9p vialfrednobel 23-12-2023 4 3 Download
-
The effects of obesity and diabetes on the clinical outcomes of differentiated thyroid cancer (DTC) remain unclear. Objectives To explore the association between obesity and diabetes with pathological features and therapeutic response of DTC.
8p vialfrednobel 23-12-2023 11 2 Download
-
The BRAF V600E mutation is one of the prognostic factors in thyroid carcinoma related to GLUT-1 expression which increases FDG uptake. In this study, we investigated the relationship between BRAF V600E mutation, clinicopathologic factors and 18F-fluoro-2-deoxyglucose (18F-FDG) avidity in radioiodine-refractory differentiated thyroid carcinoma (DTC).
8p visoros 01-11-2023 6 1 Download
-
Malignant struma ovarii is a very rare type of gynecologic cancer. Although its most common histological subtype is a pure type of papillary thyroid carcinoma containing two components, papillary carcinoma and poorly differentiated carcinoma, malignant struma ovarii is still extremely rare.
5p vigamora 23-05-2023 5 4 Download
-
The incidence of differentiated thyroid carcinoma (DTC) in Cuba is low and the contribution of host genetic factors to DTC in this population has not been investigated so far. Our goal was to assess the role of known risk polymorphisms in DTC cases living in Havana.
9p vinarcissa 21-03-2023 2 1 Download
-
Treatment for radioiodine refractory differentiated thyroid carcinoma (RR-DTC) is challenging. The purpose of this study was to assess the efficacy and safety of ultrasound-guided implantation of radioactive 125Iseed in radioiodine refractory differentiated thyroid carcinoma.
9p vimahuateng 26-11-2021 10 1 Download
-
Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
Because lenvatinib is well known to induce proteinuria by blocking the vascular endothelial growth factor (VEGF) pathway, renal function is a concern with long-term administration of lenvatinib. The long-term effects of lenvatinib on renal function in patients with advanced differentiated thyroid carcinoma (DTC) were analyzed.
11p vimahuateng 26-11-2021 9 1 Download
-
The incidence of papillary thyroid cancer (PTC) is markedly higher in women than men during the reproductive years. In vitro studies have suggested that estrogen may play an important role in the development and progression of PTC through estrogen receptors (ERs).
10p virose2711 24-09-2020 6 0 Download
-
After initial treatment of differentiated thyroid carcinoma (DTC) patients are followed with thyroglobulin (Tg) measurements to detect recurrences. In case of elevated levels of Tg and negative neck ultrasonography, patients are treated 'blindly' with Iodine-131 (131I).
8p virose2711 22-09-2020 17 2 Download
-
The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate diagnosis following FNA, are referred to surgery.
12p virose2711 22-09-2020 13 1 Download
-
Sorafenib is an orally active multikinase tyrosine kinase inhibitor (TKI) that targets B-type Raf kinase (BRAF), vascular endothelial growth factor receptors (VEGFR) 1 and 2, and rearranged during transfection (RET), inducing anti-angiogenic and pro-apoptotic actions in a wide range of solid tumors.
6p vinaypyidaw2711 26-08-2020 14 2 Download
-
The differential diagnosis of follicular thyroid carcinoma (FTC) and follicular adenoma (FA) before surgery is a clinical challenge. Many efforts have been made but most focusing on tumor cells, while the roles of tumor associated macrophages (TAMs) remained unclear in FTC.
8p vinaypyidaw2711 26-08-2020 10 1 Download
-
NKX2.5 is a transcription factor transiently expressed during thyroid organogenesis. Recently, several works have pointed out the oncogenic role of NKX2.5 in a variety of tumors. We therefore hypothesized that NKX2. 5 could also play a role in thyroid cancer.
12p vibaku2711 22-07-2020 12 2 Download
-
The advent of tyrosine kinase inhibitors (TKIs) has changed the treatment of RAI refractory, unresectable recurrent differentiated thyroid cancer (DTC), which was formerly treated with multidisciplinary remedies.
6p vibaku2711 22-07-2020 11 2 Download
-
The prognostic variability of thyroid carcinomas has led to the search for accurate biomarkers at the molecular level. Follicular thyroid carcinoma (FTC) is a typical example of differentiated thyroid carcinomas (DTC) in which challenges are faced in the differential diagnosis.
16p vibaku2711 22-07-2020 10 1 Download
-
To describe histopathological and immunoshistochemical characteristics of recurrent, metastatic differentiated thyroid carcinoma. To determine the prevalence of BRAF V600E mutation, and investigate potential association between BRAF V600E mutation and some histopathological and clinical characteristics.
27p angicungduoc6 21-07-2020 23 2 Download
-
Regarding the longer-term recurrence rate the optimal activity for the remnant thyroid ablation in patients with differentiated thyroid cancer (DTC) is discussed controversially. For the short-term ablation success rate up to 12 months there are already several meta-analyses.
9p vimanila2711 25-06-2020 9 0 Download